Eko Foundation Analysis Software with Transformers (EFAST) vs Viz HCM
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if your practice emphasizes primary care or general internal medicine and you require real-time AI assistance during routine auscultation. This tool is ideal for clinicians who want to enhance their ability to detect structural murmurs and atrial fibrillation directly at the point of care using a digital stethoscope, providing immediate, actionable insights during patient exams.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose Viz HCM if…
Choose Viz HCM if your hospital or health system needs an automated, system-wide solution for early detection and coordinated management of Hypertrophic Cardiomyopathy. This tool excels in environments where ECGs are routinely performed, enabling real-time AI analysis to identify suspected HCM and rapidly mobilize multidisciplinary care teams for timely diagnosis and treatment within an integrated healthcare system.
View Viz HCM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | Viz HCM |
|---|---|---|
| Pricing | Subscription-based, contact for details | Unknown |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST integrates seamlessly with Eko digital stethoscopes, providing real-time AI analysis directly during auscultation, which offers immediate and intuitive feedback at the point of care for the examining clinician. While Viz HCM streamlines care coordination, EFAST's direct integration into the physical exam workflow makes it highly usable for immediate diagnostic assistance.
Clinical Value
Eko Foundation Analysis Software with Transformers (EFAST)EFAST provides high sensitivity and specificity metrics for detecting both structural murmurs (93% sensitivity, 91% specificity) and atrial fibrillation (95% sensitivity, 94% specificity), addressing two common and impactful cardiac conditions. While Viz HCM offers significant value in reducing diagnosis time for HCM, EFAST's clear performance metrics across two prevalent conditions offer broader immediate diagnostic aid at the point of care.
Pricing & Value
Viz HCMViz HCM offers a clear value proposition for hospitals and health systems by highlighting the availability of CMS reimbursement for specific CPT codes (0764T and 0765T), which provides a direct pathway for cost recovery. EFAST, while subscription-based and offering a free trial with stethoscope purchase, does not provide comparable information on direct institutional reimbursement or cost-effectiveness.
Enterprise Readiness
Viz HCMViz HCM explicitly states integration with 'hospital IT systems (EHR, PACS)' and 'existing clinical workflows,' indicating a comprehensive approach to enterprise-level deployment and interoperability within complex hospital environments. While EFAST mentions EMR integration, Viz HCM's broader scope suggests greater readiness for large-scale institutional adoption and seamless workflow integration.
Innovation
Eko Foundation Analysis Software with Transformers (EFAST)EFAST leverages an 'advanced, FDA-cleared AI model' with 'Transformers' for real-time analysis during auscultation, directly enhancing a traditional physical exam with immediate, data-driven insights. This represents a significant innovation in point-of-care diagnostic technology. Viz HCM's innovation focuses more on workflow automation and rapid care coordination for a specific condition.
Support & Docs
Viz HCMViz.ai offers a comprehensive 'Knowledge Base' with help articles, tips, tutorials, and troubleshooting guides, alongside a 'Viz Academy' for user education and extensive resources like white papers and webinars. Eko Health provides user manuals and a help center, but Viz.ai's broader and more structured educational and support ecosystem suggests a more robust offering for enterprise clients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | Viz HCM |
|---|---|---|
| Tool Name | Eko Foundation Analysis Software with Transformers (EFAST) | Viz HCM |
| Company | Eko Health | Viz.ai |
| Description | EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. | Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time. |
| Primary AI Detection Focus | Structural murmurs and Atrial Fibrillation (AFib) | Hypertrophic Cardiomyopathy (HCM) |
| Key Features (AI Analysis) | AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation. | AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection; Real-time disease detection from electrocardiograms. |
| Integration | Seamless integration with Eko digital stethoscopes (e.g., CORE 500); EMR integration for streamlined documentation. | Seamless integration with existing clinical workflows, EHR, and PACS systems. |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Viz HCM.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or Viz HCM
Backers
Who funded each tool's parent company.